New insights into mechanisms of therapeutic effects of antimalarial agents in SLE. - Wikidata - wikimedia - TriplyDB

New insights into mechanisms of therapeutic effects of antimalarial agents in SLE.

New insights into mechanisms of therapeutic effects of antimalarial agents in SLE.

http://www.wikidata.org/entity/Q38026787

about

Modulation of deregulated chaperone-mediated autophagy by a phosphopeptide Inflammatory etiopathogenesis of systemic lupus erythematosus: an update The clinical relevance of animal models in Sjögren's syndrome: the interferon signature from mouse to man Modelling clinical systemic lupus erythematosus: similarities, differences and success stories Mestizos with systemic lupus erythematosus develop renal disease early while antimalarials retard its appearance: data from a Latin American cohort.Late-Onset Immune Thrombocytopenic Purpura After Withdrawal of Interferon Treatment for Chronic Hepatitis C Infection: A Case Report Chloroquine cardiomyopathy: beyond ocular adverse effects.Chloroquine binding reveals flavin redox switch function of quinone reductase 2.Quinacrine inhibits Candida albicans growth and filamentation at neutral pH.Aortic Atherosclerosis in Systemic Lupus Erythematosus Cutting edge: Antimalarial drugs inhibit IFN-β production through blockade of cyclic GMP-AMP synthase-DNA interaction.Toll-like receptors: potential targets for lupus treatment Early treatment with hydroxychloroquine prevents the development of endothelial dysfunction in a murine model of systemic lupus erythematosus.Hydroxychloroquine decreases Th17-related cytokines in systemic lupus erythematosus and rheumatoid arthritis patients Dominant Th1 and minimal Th17 skewing in discoid lupus revealed by transcriptomic comparison with psoriasis.Mitigated NSAID-induced apoptotic and autophagic cell death with Smad7 overexpression.Vasculitis associated with rheumatoid arthritis: a case-control study The Roles of Lysosomes in Inflammation and Autoimmune Diseases.Hydroxychloroquine in children with interstitial (diffuse parenchymal) lung diseases.Chloroquine analogues in drug discovery: new directions of uses, mechanisms of actions and toxic manifestations from malaria to multifarious diseases.New Perspectives in Rheumatology: Avoiding Antimalarial Toxicity.Immunomodulators in SLE: Clinical evidence and immunologic actions.Why targeted therapies are necessary for systemic lupus erythematosus.Toll-like receptor-mediated immune responses in intestinal macrophages; implications for mucosal immunity and autoimmune diseases.Treatment Algorithms in Systemic Lupus Erythematosus.Hydroxychloroquine inhibits CD154 expression in CD4+ T lymphocytes of systemic lupus erythematosus through NFAT, but not STAT5, signaling Killing of Staphylococcus aureus in murine macrophages by chloroquine used alone and in combination with ciprofloxacin or azithromycin.Genetic ablation or pharmacologic inhibition of autophagy mitigated NSAID-associated gastric damages.Curvilinear bodies are associated with adverse effects on muscle function but not with hydroxychloroquine dosing.Inhibition of autophagy by chloroquine induces apoptosis in primary effusion lymphoma in vitro and in vivo through induction of endoplasmic reticulum stress.A Case of Recurrent Kikuchi-Fujimoto Disease Successfully Treated by the Concomitant Use of Hydroxychloroquine and Corticosteroids.The effect of hydroxychloroquine on haemostasis, complement, inflammation and angiogenesis in patients with antiphospholipid antibodies.Immunosuppressive effects of hydroxychloroquine and artemisinin combination therapy via the nuclear factor-κB signaling pathway in lupus nephritis mice.Beneficial effect of hydroxychloroquine on cutaneous vasculitis in a Japanese patient with systemic lupus erythematosus.Protective Effects of Hydroxychloroquine against Accelerated Atherosclerosis in Systemic Lupus Erythematosus.

P2860

Q24320133-473B6BAE-EC84-4087-8DFB-5A4892D3D68A Q26796413-36718441-15B7-4317-926E-19EFDD65CFA1 Q26825196-29E7C137-B8CA-4B0C-913B-3F7B77126338 Q28074217-7AB46327-EEEB-442C-8667-04312DBD0400 Q30655475-CF81E262-E669-4984-9C2A-34CF9041B684 Q33425472-D05C590A-41B3-49E9-8CC5-5B0E91FCA6AE Q34198175-38997A32-5E1B-4CEF-A5AA-E7131D4D428D Q34331796-21699DEA-A0DD-4B79-8335-2A627458EE1F Q34597683-5E2FA8BD-A489-4F3E-A12C-A37F22E2272A Q34938841-540E23EA-0705-4F00-A322-A17920542CFD Q35589645-C5F2E590-ADD5-4CAA-8630-9DB5A60840AD Q35848152-CA410228-72F7-4610-B7CF-92D76ED79B04 Q36126483-743B6A61-FB66-40AC-9AF3-42B2D7B774C4 Q36906782-6C39AA1B-E1E9-4CFE-9D4F-CCC23B3CA4E6 Q37381187-F3ED925C-6861-4816-AE54-B6D47701EFA3 Q37614488-6A5F5954-D556-4E01-A305-426C2605370A Q37722841-CE6E8EDC-EC00-4947-98C2-85CFECD91263 Q38235294-1E1D66E9-D56F-4545-9E35-410063CA716D Q38285841-11425AEF-C624-46F7-A58B-DB4BCC967CA3 Q38360827-CC1996D2-B41F-4392-959B-B4676244B163 Q38816742-ED98D75A-5C79-4294-B52A-84222CE011D9 Q38883883-53FBD3F5-53EB-4D91-BF9D-394CCA868CC6 Q38920435-B583BE44-EF5B-454C-A359-1D4CFC07F84C Q38952668-92071287-8370-492A-8B35-DE24CB88EC9B Q41207949-6012E0A7-C45F-4146-A355-B474D2068FED Q41336601-DC02C8AF-9B4B-4EA4-B6F8-38B925FC91C3 Q41476422-2B173A99-6CD8-4F76-9697-9F3559929308 Q41913804-130E0D68-EA26-4D8E-B53F-696B6A639931 Q41914287-A6BD89B0-2B12-4C37-846B-680E69DAFCAB Q41914515-D7067496-4541-498B-AC16-02DB247948B2 Q41922137-85880898-78F3-41D7-A70C-900CF44088DC Q45873335-FDC86015-8D03-4CEF-A35E-6DA96D52D8B7 Q49884436-E93B3A93-40FF-46F0-A4BD-90E1404C3F47 Q50229972-B213CE6D-3D2A-4F5B-8E33-A31DEADF5E6C Q52316454-FA6B5877-6444-45CE-824C-AC3B366067B0

P2860

New insights into mechanisms of therapeutic effects of antimalarial agents in SLE.

http://www.wikidata.org/entity/Q38026787

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

New insights into mechanisms of therapeutic effects of antimalarial agents in SLE.

@en

type

label

New insights into mechanisms of therapeutic effects of antimalarial agents in SLE.

@en

prefLabel

New insights into mechanisms of therapeutic effects of antimalarial agents in SLE.

@en

P1433

Q38026787-519ED349-0D60-4775-8B0A-67399BC8DB05

P1476

Q38026787-761E189C-EA99-4C6B-9F09-5E60C0EA3C76

P2093

Q38026787-1801CE8F-39DC-4B2B-99CD-C7F838A28033

Q38026787-6A3869FA-5500-485F-9C74-A040408E28E4

Q38026787-792DB38B-89F8-44ED-B8F2-7A503CA429EA

Q38026787-DF34BFB7-33CC-450C-B9E7-E041B74FAF55

P2860

Q38026787-0527B627-8A58-4D50-A650-E105E01FDBB4

Q38026787-07230528-C63E-4E0F-84A9-B74DA4FD1160

Q38026787-08458998-0E05-4BDF-8FC0-7FA8D68D8656

Q38026787-0C6D1880-B22B-488A-8890-8528999170BC

Q38026787-0E611FB5-4A7C-4A0C-B9BE-85A49564793F

Q38026787-0E8385E0-3A89-4E87-91E6-41F19AB8F72E

Q38026787-126AB9C1-893A-4A9F-BD8E-9FE5D901AE94

Q38026787-13E4222A-1979-4185-9096-C7FC03009526

Q38026787-163F7F3D-E31D-45D7-9414-2F5AE3C8AF10

Q38026787-1BE4B922-DEAA-4E90-8146-8B458FEDD0C6

P2888

Q38026787-0CF79971-D624-4E9E-9B68-0C466FB5CE82

P304

Q38026787-4049E675-0C9E-4BDE-8163-1ED2F23B0CDB

P31

Q38026787-48E57DC0-D643-44FD-B96A-C9A085C4659E

P356

Q38026787-CD910480-ED4A-4C3A-8FF3-3A37ADBBE6DD

P407

Q38026787-DDFBE18D-BC9F-43A5-AB5D-071226B95CF5

P433

Q38026787-38E6ED20-BEA3-4191-B341-A6C497A1EBA9

P478

Q38026787-BEBBE5DA-2E96-4F34-8B65-4548C5F671BC

P577

Q38026787-FC00CAD3-2331-4910-B3B6-F889E8F78DDD

P6179

Q38026787-E4C7361F-E73C-415B-808B-F6A36F6F2FB1

P698

Q38026787-6FF81E0F-FA6E-4F0C-AA64-E06BE4EFFC41

P921

Q38026787-9FBD04A6-D90F-4697-BBD7-23CC5A220BD5

P356

NRRHEUM.2012.106

P1433

Nature Reviews Rheumatology

P1476

New insights into mechanisms of therapeutic effects of antimalarial agents in SLE.

@en

P2093

Daniel J Wallace

http://www.w3.org/2001/XMLSchema#string

Michael H Weisman

http://www.w3.org/2001/XMLSchema#string

Swamy R Venuturupalli

http://www.w3.org/2001/XMLSchema#string

Vineet S Gudsoorkar

http://www.w3.org/2001/XMLSchema#string

P2860

DrugBank 3.0: a comprehensive resource for 'omics' research on drugs

Safety and efficacy of quinacrine in human prion disease (PRION-1 study): a patient-preference trial

Beyond DNA binding - a review of the potential mechanisms mediating quinacrine's therapeutic activities in parasitic infections, inflammation, and cancers

The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor.

Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L)

Cigarette smoke upregulates pulmonary vascular matrix metalloproteinases via TNF-alpha signaling.

Hydroxychloroquine in lupus pregnancy.

Protective effect of hydroxychloroquine on renal damage in patients with lupus nephritis: LXV, data from a multiethnic US cohort.

Antimalarial treatment may have a time-dependent effect on lupus survival: data from a multinational Latin American inception cohort.

Possible protective effect of hydroxychloroquine on delaying the occurrence of integument damage in lupus: LXXI, data from a multiethnic cohort.

P2888

nrrheum.2012.106

P304

522-533

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRRHEUM.2012.106

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2012-07-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1030064389

http://www.w3.org/2001/XMLSchema#string

P698

22801982

http://www.w3.org/2001/XMLSchema#string

P921